1. Home
  2. ORKT vs COEP Comparison

ORKT vs COEP Comparison

Compare ORKT & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORKT
  • COEP
  • Stock Information
  • Founded
  • ORKT 2003
  • COEP 2017
  • Country
  • ORKT Singapore
  • COEP United States
  • Employees
  • ORKT N/A
  • COEP N/A
  • Industry
  • ORKT
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ORKT
  • COEP Health Care
  • Exchange
  • ORKT NYSE
  • COEP Nasdaq
  • Market Cap
  • ORKT 34.7M
  • COEP 32.4M
  • IPO Year
  • ORKT 2024
  • COEP N/A
  • Fundamental
  • Price
  • ORKT $1.23
  • COEP $12.45
  • Analyst Decision
  • ORKT Strong Buy
  • COEP
  • Analyst Count
  • ORKT 1
  • COEP 0
  • Target Price
  • ORKT $5.00
  • COEP N/A
  • AVG Volume (30 Days)
  • ORKT 6.9M
  • COEP 111.8K
  • Earning Date
  • ORKT 10-16-2024
  • COEP 03-25-2025
  • Dividend Yield
  • ORKT N/A
  • COEP N/A
  • EPS Growth
  • ORKT N/A
  • COEP N/A
  • EPS
  • ORKT N/A
  • COEP N/A
  • Revenue
  • ORKT $3,904,592.00
  • COEP N/A
  • Revenue This Year
  • ORKT N/A
  • COEP N/A
  • Revenue Next Year
  • ORKT N/A
  • COEP N/A
  • P/E Ratio
  • ORKT N/A
  • COEP N/A
  • Revenue Growth
  • ORKT N/A
  • COEP N/A
  • 52 Week Low
  • ORKT $0.62
  • COEP $2.31
  • 52 Week High
  • ORKT $8.00
  • COEP $13.70
  • Technical
  • Relative Strength Index (RSI)
  • ORKT N/A
  • COEP 63.21
  • Support Level
  • ORKT N/A
  • COEP $8.65
  • Resistance Level
  • ORKT N/A
  • COEP $12.95
  • Average True Range (ATR)
  • ORKT 0.00
  • COEP 1.64
  • MACD
  • ORKT 0.00
  • COEP -0.16
  • Stochastic Oscillator
  • ORKT 0.00
  • COEP 75.25

About ORKT ORANGEKLOUD TECHNOLOGY INC

Orangekloud Technology Inc is a company that operates through its subsidiaries provide IT consultancy services and distribution of related products and services. The Company also offers ERPs predominately in Singapore. It derives revenue from platform subscriptions, license and products and professional services.

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Share on Social Networks: